Unwinding fibril formation of medin, the peptide of the most common form of human amyloid

被引:33
|
作者
Larsson, Annika
Soderberg, Linda
Westermark, Gunilla T.
Sletten, Knut
Engstrom, Ulla
Tjernberg, Lars O.
Naslund, Jan
Westermark, Per [1 ]
机构
[1] Uppsala Univ, Dept Genet & Pathol, Rudbeck Lab, SE-75185 Uppsala, Sweden
[2] Karolinska Inst, KASPAC, Dept NVS, Huddinge, Sweden
[3] Linkoping Univ, Ctr Diabet Res, Div Cell Biol, Linkoping, Sweden
[4] Univ Oslo, Biotechnol Ctr Oslo, Oslo, Norway
[5] Ludwig Inst Canc Res, S-75124 Uppsala, Sweden
关键词
amyloid; fibril formation; lactadherin; medin;
D O I
10.1016/j.bbrc.2007.06.187
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Medin amyloid affects the medial layer of the thoracic aorta of most people above 50 years of age. The consequences of this amyloid are not completely known but the deposits may contribute to diseases such as thoracic aortic aneurysm and dissection or to the general diminished elasticity of blood vessels seen in elderly people. We show that the 50-amino acid residue peptide medin forms amyloid-like fibrils in vitro. With the use of Congo red staining, Thioflavin T fluorescence, electron microscopy, and a solid-phase binding assay on different synthetic peptides, we identified the last 18-19 amino acid residues to constitute the amyloid-promoting region of medin. We also demonstrate that the two C-terminal phenylalanines, previously suggested to be of importance for amyloid formation, are not required for medin amyloid formation. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:822 / 828
页数:7
相关论文
共 50 条
  • [21] α2-macroglobulin associates with β-amyloid peptide and prevents fibril formation
    Hughes, SR
    Khorkova, O
    Goyal, S
    Knaeblein, J
    Heroux, J
    Riedel, NG
    Sahasrabudhe, S
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (06) : 3275 - 3280
  • [22] Inhibition of amyloid fibril formation by peptide analogues modified with α-aminoisobutyric acid
    Gilead, S
    Gazit, E
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2004, 43 (31) : 4041 - 4044
  • [23] A mobile precursor determines amyloid-β peptide fibril formation at interfaces
    Zhu, X.-Y. (zhu@cm.utexas.edu), 1600, American Chemical Society (134):
  • [24] Inhibition of amyloid peptide fibril formation by gold-sulfur complexes
    Wang, Wenji
    Zhao, Cong
    Zhu, Dengsen
    Gong, Gehui
    Du, Weihong
    JOURNAL OF INORGANIC BIOCHEMISTRY, 2017, 171 : 1 - 9
  • [25] Mechanistic insights into oligomer and fibril formation of amyloid-beta peptide
    Du, Deguo
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 255
  • [26] A Mobile Precursor Determines Amyloid-β Peptide Fibril Formation at Interfaces
    Shen, Lei
    Adachi, Takuji
    Vanden Bout, David
    Zhu, X. -Y.
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2012, 134 (34) : 14172 - 14178
  • [27] Structural requirements of glycosaminoglycans for facilitating amyloid fibril formation of human serum amyloid A
    Takase, Hiroka
    Tanaka, Masafumi
    Yamamoto, Aki
    Watanabe, Shiori
    Takahashi, Sanae
    Nadanaka, Satomi
    Kitagawa, Hiroshi
    Yamada, Toshiyuki
    Mukai, Takahiro
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2016, 23 (02): : 67 - 75
  • [28] Oligopeptide-mediated acceleration of amyloid fibril formation of amyloid β(Aβ) and α-synuclein fragment peptide (NAC)
    Kuroda, Y
    Maeda, Y
    Hanaoka, H
    Miyamoto, K
    Nakagawa, T
    JOURNAL OF PEPTIDE SCIENCE, 2004, 10 (01) : 8 - 17
  • [29] FIBRIL FORMATION FROM RECOMBINANT HUMAN SERUM AMYLOID-A
    YAMADA, T
    KLUVEBECKERMAN, B
    LIEPNIEKS, JJ
    BENSON, MD
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1994, 1226 (03): : 323 - 329
  • [30] Inhibition of amyloid beta fibril formation by monomeric human transthyretin
    Garai, Kanchan
    Posey, Ammon E.
    Li, Xinyi
    Buxbaum, Joel N.
    Pappu, Rohit V.
    PROTEIN SCIENCE, 2018, 27 (07) : 1252 - 1261